Regenerative Medical Technology Group annual operating margin
2023
2024
2025
Regenerative Medical Technology Group Operating Margin Growth & History (RMTG)
Regenerative Medical Technology Group's operating margin was −17.00% for fiscal 2025.
View full Regenerative Medical Technology Group company overviewRegenerative Medical Technology Group annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −17.00% | −18.98 pp |
| 2024 | 2024-12-31 | 1.98% | +31.65 pp |
| 2023 | 2023-12-31 | −29.68% | — |
Regenerative Medical Technology Group quarterly operating margin
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 14.07% | +39.50 pp |
| Q1 2026 | 2026-03-31 | 8.71% | −1.19 pp |
| Q4 2025 | 2025-12-31 | −19.48% | −44.67 pp |
| Q3 2025 | 2025-09-30 | −37.76% | −39.75 pp |
| Q2 2025 | 2025-06-30 | −25.43% | +1.54 pp |
| Q1 2025 | 2025-03-31 | 9.89% | +22.76 pp |
| Q4 2024 | 2024-12-31 | 25.19% | — |
| Q3 2024 | 2024-09-30 | 1.99% | — |
| Q2 2024 | 2024-06-30 | −26.97% | — |
| Q1 2024 | 2024-03-31 | −12.86% | — |
Regenerative Medical Technology Group operating margin trends
Across the available reported history, Regenerative Medical Technology Group's operating margin decreased from 1.98% to −17.00%, a change of −18.98 percentage points. The latest reported quarter, Q2 2026, shows 14.07%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regenerative Medical Technology Group filings at SEC.gov ↗